HEADER TRANSFERASE 05-JAN-22 7QPN TITLE CRYSTAL STRUCTURE OF PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE TITLE 2 (PI5P4K2C) BOUND TO AN ALLOSTERIC INHIBITOR AND AMP-PNP COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE (PI5P4K2C); COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_VARIANT: GOLD KEYWDS ALLOSTERIC BINDING, LIPID KINASE, NON-ATP-COMPETITIVE INHIBITOR, KEYWDS 2 PHOSPHATIDYLINOSITOL 5-PHOSPHATE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.D.HOWARD,D.T.OGG REVDAT 4 31-JAN-24 7QPN 1 REMARK REVDAT 3 17-AUG-22 7QPN 1 JRNL REVDAT 2 10-AUG-22 7QPN 1 JRNL REVDAT 1 18-MAY-22 7QPN 0 JRNL AUTH H.K.BOFFEY,T.P.C.ROONEY,H.M.G.WILLEMS,S.EDWARDS,C.GREEN, JRNL AUTH 2 T.HOWARD,D.OGG,T.ROMERO,D.E.SCOTT,D.WINPENNY,J.DUCE, JRNL AUTH 3 J.SKIDMORE,J.H.CLARKE,S.P.ANDREWS JRNL TITL DEVELOPMENT OF SELECTIVE PHOSPHATIDYLINOSITOL 5-PHOSPHATE JRNL TITL 2 4-KINASE GAMMA INHIBITORS WITH A NON-ATP-COMPETITIVE, JRNL TITL 3 ALLOSTERIC BINDING MODE. JRNL REF J.MED.CHEM. V. 65 3359 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35148092 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01819 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 116.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 74.0 REMARK 3 NUMBER OF REFLECTIONS : 37666 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1877 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 33 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.3190 REMARK 3 BIN FREE R VALUE SET COUNT : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5133 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 116 REMARK 3 SOLVENT ATOMS : 210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.68000 REMARK 3 B22 (A**2) : -0.54000 REMARK 3 B33 (A**2) : 1.22000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.248 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.218 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.160 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.015 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5406 ; 0.010 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 5077 ; 0.001 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7308 ; 1.596 ; 1.644 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11689 ; 1.227 ; 1.603 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 623 ; 7.047 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 295 ;32.602 ;22.305 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 945 ;18.718 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;17.389 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 665 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6349 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1261 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7QPN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-JAN-22. REMARK 100 THE DEPOSITION ID IS D_1292119649. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-APR-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39543 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 116.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 56.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2GK9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG5KMME, 0.3M AMMONIUM TARTRATE, REMARK 280 100MM PCTP, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.81250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 32 REMARK 465 PHE A 33 REMARK 465 VAL A 34 REMARK 465 GLN A 35 REMARK 465 GLN A 36 REMARK 465 GLY A 136 REMARK 465 SER A 137 REMARK 465 ASP A 138 REMARK 465 GLU A 341 REMARK 465 LEU A 342 REMARK 465 GLY A 343 REMARK 465 LYS A 384 REMARK 465 ALA A 385 REMARK 465 ALA A 386 REMARK 465 HIS A 387 REMARK 465 ALA A 388 REMARK 465 ALA A 389 REMARK 465 LYS A 390 REMARK 465 THR A 391 REMARK 465 VAL A 392 REMARK 465 LYS A 393 REMARK 465 HIS A 394 REMARK 465 GLY A 395 REMARK 465 ALA A 396 REMARK 465 GLY A 397 REMARK 465 ALA A 398 REMARK 465 GLU A 399 REMARK 465 ILE A 400 REMARK 465 SER A 401 REMARK 465 THR A 402 REMARK 465 ALA A 421 REMARK 465 HIS B 32 REMARK 465 PHE B 33 REMARK 465 VAL B 34 REMARK 465 GLN B 35 REMARK 465 GLN B 36 REMARK 465 LYS B 37 REMARK 465 LEU B 342 REMARK 465 GLY B 343 REMARK 465 PRO B 344 REMARK 465 TYR B 379 REMARK 465 ASP B 380 REMARK 465 ALA B 381 REMARK 465 LYS B 382 REMARK 465 LYS B 383 REMARK 465 LYS B 384 REMARK 465 ALA B 385 REMARK 465 ALA B 386 REMARK 465 HIS B 387 REMARK 465 ALA B 388 REMARK 465 ALA B 389 REMARK 465 LYS B 390 REMARK 465 THR B 391 REMARK 465 VAL B 392 REMARK 465 LYS B 393 REMARK 465 HIS B 394 REMARK 465 GLY B 395 REMARK 465 ALA B 396 REMARK 465 GLY B 397 REMARK 465 ALA B 398 REMARK 465 GLU B 399 REMARK 465 ILE B 400 REMARK 465 SER B 401 REMARK 465 THR B 402 REMARK 465 VAL B 403 REMARK 465 ALA B 421 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 92 CD OE1 OE2 REMARK 470 LEU A 223 CG CD1 CD2 REMARK 470 SER A 225 OG REMARK 470 LYS A 233 CD CE NZ REMARK 470 ILE A 291 CD1 REMARK 470 GLU A 295 CG CD OE1 OE2 REMARK 470 GLU A 297 CG CD OE1 OE2 REMARK 470 GLU A 348 CD OE1 OE2 REMARK 470 GLU A 360 CG CD OE1 OE2 REMARK 470 ILE A 375 CD1 REMARK 470 LYS A 383 CG CD CE NZ REMARK 470 VAL B 38 CG1 CG2 REMARK 470 LYS B 39 CG CD CE NZ REMARK 470 SER B 225 OG REMARK 470 GLU B 295 CG CD OE1 OE2 REMARK 470 GLU B 299 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 109 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG B 226 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 95 -178.57 -64.61 REMARK 500 ARG A 210 -45.05 -146.45 REMARK 500 LEU A 211 109.31 -52.31 REMARK 500 SER A 229 174.63 -56.17 REMARK 500 MET A 279 -67.69 -127.26 REMARK 500 GLU A 297 39.76 -86.64 REMARK 500 SER A 358 126.83 -32.85 REMARK 500 TYR A 379 70.15 -67.50 REMARK 500 ASP A 380 147.12 -170.58 REMARK 500 ALA A 381 103.49 -54.54 REMARK 500 LYS A 382 130.51 -28.93 REMARK 500 VAL B 40 121.74 -31.18 REMARK 500 ASP B 194 -137.13 65.56 REMARK 500 ASN B 195 50.17 -115.73 REMARK 500 ARG B 210 -20.19 -149.23 REMARK 500 ASP B 280 21.73 83.28 REMARK 500 GLU B 360 -58.02 -27.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7QIE RELATED DB: PDB REMARK 900 7QIE CONTAINS SAME PROTEINS AND LIGAND, IN THE ABSENCE OF AMPPNP DBREF 7QPN A 32 421 PDB 7QPN 7QPN 32 421 DBREF 7QPN B 32 421 PDB 7QPN 7QPN 32 421 SEQRES 1 A 348 HIS PHE VAL GLN GLN LYS VAL LYS VAL PHE ARG ALA ALA SEQRES 2 A 348 ASP PRO LEU VAL GLY VAL PHE LEU TRP GLY VAL ALA HIS SEQRES 3 A 348 SER ILE ASN GLU LEU SER GLN VAL PRO PRO PRO VAL MET SEQRES 4 A 348 LEU LEU PRO ASP ASP PHE LYS ALA SER SER LYS ILE LYS SEQRES 5 A 348 VAL ASN ASN HIS LEU PHE HIS ARG GLU ASN LEU PRO SER SEQRES 6 A 348 HIS PHE LYS PHE LYS GLU TYR CYS PRO GLN VAL PHE ARG SEQRES 7 A 348 ASN LEU ARG ASP ARG PHE GLY ILE ASP ASP GLN ASP TYR SEQRES 8 A 348 LEU VAL SER LEU THR ARG ASN PRO PRO SER GLU SER GLU SEQRES 9 A 348 GLY SER ASP GLY ARG PHE LEU ILE SER TYR ASP ARG THR SEQRES 10 A 348 LEU VAL ILE LYS GLU VAL SER SER GLU ASP ILE ALA ASP SEQRES 11 A 348 MET HIS SER ASN LEU SER ASN TYR HIS GLN TYR ILE VAL SEQRES 12 A 348 LYS CYS HIS GLY ASN THR LEU LEU PRO GLN PHE LEU GLY SEQRES 13 A 348 MET TYR ARG VAL SER VAL ASP ASN GLU ASP SER TYR MET SEQRES 14 A 348 LEU VAL MET ARG ASN MET PHE SER HIS ARG LEU PRO VAL SEQRES 15 A 348 HIS ARG LYS TYR ASP LEU LYS GLY SER LEU VAL SER ARG SEQRES 16 A 348 GLU ALA SER ASP LYS GLU LYS VAL LYS GLU LEU PRO THR SEQRES 17 A 348 LEU LYS ASP MET ASP PHE LEU ASN LYS ASN GLN LYS VAL SEQRES 18 A 348 TYR ILE GLY GLU GLU GLU LYS LYS ILE PHE LEU GLU LYS SEQRES 19 A 348 LEU LYS ARG ASP VAL GLU PHE LEU VAL GLN LEU LYS ILE SEQRES 20 A 348 MET ASP TYR SER LEU LEU LEU GLY ILE HIS ASP ILE ILE SEQRES 21 A 348 ARG GLY SER GLU PRO GLU GLU GLU LEU GLY PRO GLY GLU SEQRES 22 A 348 PHE GLU SER PHE ILE ASP VAL TYR ALA ILE ARG SER ALA SEQRES 23 A 348 GLU GLY ALA PRO GLN LYS GLU VAL TYR PHE MET GLY LEU SEQRES 24 A 348 ILE ASP ILE LEU THR GLN TYR ASP ALA LYS LYS LYS ALA SEQRES 25 A 348 ALA HIS ALA ALA LYS THR VAL LYS HIS GLY ALA GLY ALA SEQRES 26 A 348 GLU ILE SER THR VAL HIS PRO GLU GLN TYR ALA LYS ARG SEQRES 27 A 348 PHE LEU ASP PHE ILE THR ASN ILE PHE ALA SEQRES 1 B 348 HIS PHE VAL GLN GLN LYS VAL LYS VAL PHE ARG ALA ALA SEQRES 2 B 348 ASP PRO LEU VAL GLY VAL PHE LEU TRP GLY VAL ALA HIS SEQRES 3 B 348 SER ILE ASN GLU LEU SER GLN VAL PRO PRO PRO VAL MET SEQRES 4 B 348 LEU LEU PRO ASP ASP PHE LYS ALA SER SER LYS ILE LYS SEQRES 5 B 348 VAL ASN ASN HIS LEU PHE HIS ARG GLU ASN LEU PRO SER SEQRES 6 B 348 HIS PHE LYS PHE LYS GLU TYR CYS PRO GLN VAL PHE ARG SEQRES 7 B 348 ASN LEU ARG ASP ARG PHE GLY ILE ASP ASP GLN ASP TYR SEQRES 8 B 348 LEU VAL SER LEU THR ARG ASN PRO PRO SER GLU SER GLU SEQRES 9 B 348 GLY SER ASP GLY ARG PHE LEU ILE SER TYR ASP ARG THR SEQRES 10 B 348 LEU VAL ILE LYS GLU VAL SER SER GLU ASP ILE ALA ASP SEQRES 11 B 348 MET HIS SER ASN LEU SER ASN TYR HIS GLN TYR ILE VAL SEQRES 12 B 348 LYS CYS HIS GLY ASN THR LEU LEU PRO GLN PHE LEU GLY SEQRES 13 B 348 MET TYR ARG VAL SER VAL ASP ASN GLU ASP SER TYR MET SEQRES 14 B 348 LEU VAL MET ARG ASN MET PHE SER HIS ARG LEU PRO VAL SEQRES 15 B 348 HIS ARG LYS TYR ASP LEU LYS GLY SER LEU VAL SER ARG SEQRES 16 B 348 GLU ALA SER ASP LYS GLU LYS VAL LYS GLU LEU PRO THR SEQRES 17 B 348 LEU LYS ASP MET ASP PHE LEU ASN LYS ASN GLN LYS VAL SEQRES 18 B 348 TYR ILE GLY GLU GLU GLU LYS LYS ILE PHE LEU GLU LYS SEQRES 19 B 348 LEU LYS ARG ASP VAL GLU PHE LEU VAL GLN LEU LYS ILE SEQRES 20 B 348 MET ASP TYR SER LEU LEU LEU GLY ILE HIS ASP ILE ILE SEQRES 21 B 348 ARG GLY SER GLU PRO GLU GLU GLU LEU GLY PRO GLY GLU SEQRES 22 B 348 PHE GLU SER PHE ILE ASP VAL TYR ALA ILE ARG SER ALA SEQRES 23 B 348 GLU GLY ALA PRO GLN LYS GLU VAL TYR PHE MET GLY LEU SEQRES 24 B 348 ILE ASP ILE LEU THR GLN TYR ASP ALA LYS LYS LYS ALA SEQRES 25 B 348 ALA HIS ALA ALA LYS THR VAL LYS HIS GLY ALA GLY ALA SEQRES 26 B 348 GLU ILE SER THR VAL HIS PRO GLU GLN TYR ALA LYS ARG SEQRES 27 B 348 PHE LEU ASP PHE ILE THR ASN ILE PHE ALA HET DVF A 501 27 HET ANP A 502 31 HET ANP B 501 31 HET DVF B 502 54 HETNAM DVF 5-METHYL-2-(2-PROPAN-2-YLPHENYL)-~{N}-(PYRIDIN-2- HETNAM 2 DVF YLMETHYL)PYRROLO[3,2-D]PYRIMIDIN-4-AMINE HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER FORMUL 3 DVF 2(C22 H23 N5) FORMUL 4 ANP 2(C10 H17 N6 O12 P3) FORMUL 7 HOH *210(H2 O) HELIX 1 AA1 ASP A 45 SER A 63 1 19 HELIX 2 AA2 LEU A 72 LYS A 77 5 6 HELIX 3 AA3 CYS A 104 PHE A 115 1 12 HELIX 4 AA4 ASP A 118 ARG A 128 1 11 HELIX 5 AA5 SER A 155 HIS A 177 1 23 HELIX 6 AA6 SER A 229 VAL A 234 1 6 HELIX 7 AA7 LYS A 241 LYS A 248 1 8 HELIX 8 AA8 GLY A 255 LEU A 276 1 22 HELIX 9 AA9 HIS A 404 ASN A 418 1 15 HELIX 10 AB1 ASP B 45 SER B 63 1 19 HELIX 11 AB2 CYS B 104 PHE B 115 1 12 HELIX 12 AB3 ASP B 118 ARG B 128 1 11 HELIX 13 AB4 SER B 155 HIS B 177 1 23 HELIX 14 AB5 SER B 229 VAL B 234 1 6 HELIX 15 AB6 LYS B 241 LYS B 248 1 8 HELIX 16 AB7 GLY B 255 LEU B 276 1 22 HELIX 17 AB8 GLU B 295 GLU B 299 5 5 HELIX 18 AB9 PRO B 405 ASN B 418 1 14 SHEET 1 AA114 SER A 132 SER A 134 0 SHEET 2 AA114 PHE A 141 ILE A 143 -1 O PHE A 141 N SER A 134 SHEET 3 AA114 LEU A 149 VAL A 154 -1 O ILE A 151 N LEU A 142 SHEET 4 AA114 GLU A 196 ARG A 204 -1 O LEU A 201 N LYS A 152 SHEET 5 AA114 PHE A 185 VAL A 193 -1 N TYR A 189 O MET A 200 SHEET 6 AA114 HIS A 97 TYR A 103 -1 N LYS A 101 O ARG A 190 SHEET 7 AA114 SER A 79 HIS A 87 -1 N SER A 80 O GLU A 102 SHEET 8 AA114 SER B 79 HIS B 87 -1 O ASN B 85 N LYS A 81 SHEET 9 AA114 HIS B 97 TYR B 103 -1 O PHE B 98 N VAL B 84 SHEET 10 AA114 PHE B 185 VAL B 193 -1 O SER B 192 N LYS B 99 SHEET 11 AA114 GLU B 196 ARG B 204 -1 O MET B 200 N TYR B 189 SHEET 12 AA114 LEU B 149 VAL B 154 -1 N LYS B 152 O LEU B 201 SHEET 13 AA114 PHE B 141 ILE B 143 -1 N LEU B 142 O ILE B 151 SHEET 14 AA114 SER B 132 GLU B 133 -1 N SER B 132 O ILE B 143 SHEET 1 AA2 5 THR A 239 LEU A 240 0 SHEET 2 AA2 5 ARG A 215 LEU A 219 1 N LYS A 216 O LEU A 240 SHEET 3 AA2 5 SER A 282 ASP A 289 -1 O ILE A 287 N ARG A 215 SHEET 4 AA2 5 GLU A 366 ILE A 373 -1 O VAL A 367 N HIS A 288 SHEET 5 AA2 5 ALA A 355 ARG A 357 -1 N ILE A 356 O TYR A 368 SHEET 1 AA3 5 THR B 239 LEU B 240 0 SHEET 2 AA3 5 ARG B 215 LEU B 219 1 N ASP B 218 O LEU B 240 SHEET 3 AA3 5 SER B 282 ASP B 289 -1 O LEU B 285 N TYR B 217 SHEET 4 AA3 5 GLU B 366 ILE B 373 -1 O ILE B 373 N SER B 282 SHEET 5 AA3 5 ALA B 355 ARG B 357 -1 N ILE B 356 O TYR B 368 CRYST1 47.921 65.625 117.120 90.00 93.16 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020868 0.000000 0.001154 0.00000 SCALE2 0.000000 0.015238 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008551 0.00000